药品价格多方谈判主体及其事权划分研究

Research on the subjects and division of their responsibilities in multilateral drug price negotiation

通过对药品价格多方谈判政策实施现状的阐述,提出谈判主体事权划分的意义及原则,并具体划分了四个谈判主体——政府、医保、医疗机构(专家)和药品生产企业在谈判过程中的事权。

This paper elaborated the present status proposed the significance and principles of dividing the of the implementation of the multilateral drug price negotiation, responsibilities of negotiation subjects, and specifically divided the responsibilities of four negotiation subjects： government, health insurance, medical facilities（experts） and drug industries in the process of negotiation.